Medical ethics committee approves of anti-Covid drug Lagevrio
Ljubljana, 7 December - Slovenia's national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir. The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death.
The rest of this news item is available to subscribers.
The news item consists of 1.173 characters (without spaces) or 226 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.